Literature DB >> 4214761

Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.

D Bitter-Suermann, M Dierich, W König, U Hadding.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4214761      PMCID： PMC1407940     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  14 in total

1.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

2.  Reactive haemolysis--a distinctive form of red cell lysis.

Authors:  R A Thompson; D S Rowe
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

3.  Ultracentrifugation of the first component of complement: effects of ionic strength.

Authors:  H R Colten; T Borsos; H J Rapp
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

4.  Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.

Authors:  R J Pickering; M R Wolfson; R A Good; H Gewurz
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

5.  [Measurement of complement with a microliter method].

Authors:  R Ringelmann; W Opferkuch; M Röllinghoff; M Loos
Journal:  Z Med Mikrobiol Immunol       Date:  1969

6.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

7.  Multiple nature of the third component of guinea-pig complement. II. Separation and description of two additional factors beta and d; preparation and characterization of four intermediate products.

Authors:  H J Wellensiek; P G Klein
Journal:  Immunology       Date:  1965-06       Impact factor: 7.397

8.  Multiple nature of the third component of guinea-pig complement. I. Separation and characterization of three factors a, b, and c, essential for haemolysis.

Authors:  P G Klein; H J Wellensiek
Journal:  Immunology       Date:  1965-06       Impact factor: 7.397

9.  Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

Authors:  P J Lachmann; R A Thompson
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

10.  Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.

Authors:  R A Thompson; P J Lachmann
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307
View more
  15 in total

1.  Antibodies to Acholeplasma laidlawii membrane lipids in normal guinea pig serum.

Authors:  I Dörner; H Brunner; H G Schiefer; M Loos; H J Wellensiek
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

2.  Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency.

Authors:  M P Dierich; D Bitter-Suermann; W König; U Hadding; C Galanos; E T Rietschel
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

3.  [Activation of complement--an exclusive domain of immune complexes?].

Authors:  D Bitter-Suermann
Journal:  Klin Wochenschr       Date:  1972-03-15

4.  The mechanism behind the effect of ALG on platelets in vivo.

Authors:  A Henricsson; B Husberg; S E Bergentz
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

5.  Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.

Authors:  C A Alper; H R Colten; J S Gear; A R Rabson; F S Rosen
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

6.  Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.

Authors:  S Meuer; T E Hugli; R H Andreatta; U Hadding; D Bitter-Suermann
Journal:  Inflammation       Date:  1981-12       Impact factor: 4.092

7.  Relationship between biological activities of polymers. I. Immunogenicity, C3 activation, mitogenicity for B cells and adjuvant properties.

Authors:  T Diamantstein; E Blitstein-Willinger
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

8.  Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.

Authors:  J Hamuro; U Hadding; D Bitter-Suermann
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

9.  Dextran sulphate: a synthetic activator of C3 via the alternative pathway. I. Influence of molecular size and degree of sulphation on the activation potency.

Authors:  R Burger; U Hadding; H U Schorlemmer; V Brade; D Bitter-Suermann
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

10.  Studies on C3 convertases. Inhibition of C5 convertase formation by peptides containing aromatic amino acids.

Authors:  A Kossorotow; W Opitz; E Etschenberg; U Hadding
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.